Skip to main content

Flecainide (International)

In the US, Flecainide (flecainide systemic) is a member of the drug class group I antiarrhythmics and is used to treat Atrial Fibrillation, Atrial Flutter, Paroxysmal Supraventricular Tachycardia, Supraventricular Tachycardia, Ventricular Tachycardia and Wolff-Parkinson-White Syndrome.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antiarrhythmic agent, class Ic

Chemical Name

Benzamide, N-(2-piperidinylmetyl)-2,5-bis(2,2,2-trifluoroetoxy)-

Foreign Names

  • Flecainidum (Latin)
  • Flecainid (German)
  • Flécaïnide (French)
  • Flecainida (Spanish)

Generic Names

  • Flecainide (OS: DCIT, BAN)
  • Flécaïnide (OS: DCF)
  • Flecainide Acetate (OS: BANM, USAN, JAN)
  • R 818 (IS)
  • Flecainidacetat (PH: Ph. Eur. 9)
  • Flécaïnide (acétate de) (PH: Ph. Eur. 9)
  • Flecainide acetate (PH: Ph. Eur. 9)
  • Flecainide Acetate (PH: BP 2018, JP XVII, USP 41)
  • Flecainidi acetas (PH: Ph. Eur. 9)

Brand Names

  • Apocard
    Meda, Portugal
  • Diondel
    Roemmers, Argentina
  • Flecagamma
    Woerwag Pharma, Latvia
  • Flecaine
    3M Health Care, Lebanon; Meda, Tunisia
  • Flecaine LP
    Meda, Tunisia
  • Flekanid
    Laboratorios Liconsa, Serbia
  • Flenomid XR
    Elea, Argentina
  • Tambocor
    Sanolabor, Slovenia
  • Almarytm
    Meda, Italy
  • Amarhyton 100mg
    Tchaikapharma, Bulgaria
  • Amarhyton 150mg
    Tchaikapharma, Bulgaria
  • Amarhyton 200mg
    Tchaikapharma, Bulgaria
  • Amarhyton 50mg
    Tchaikapharma, Bulgaria
  • Apocard
    Meda Pharma Sau, Spain
  • Apocard Retard
    Meda Pharma, Belgium
  • Apocard Retard 100mg
    Meda, Luxembourg
  • Apocard Retard 150mg
    Meda, Luxembourg
  • Apocard Retard 200mg
    Meda, Luxembourg
  • Apo-Flecainide
    Apotex, Hong Kong
  • Aristocor 10 mg/ml
    Meda Pharm, Austria
  • Aristocor 100 mg
    Meda Pharm, Austria
  • Auro-Flecainide
    Auro Pharma, Canada
  • Diondel
    Pharma Investi de Chile, Chile; Roemmers, Uruguay
  • Flecadura
    Mylan dura, Germany
  • Flecagamma
    Wörwag Pharma, Germany
  • Flécaïne
    Meda, France
  • Flécaïne LP
    Meda, France
  • Flecainid - 1 A Pharma
    1 A Pharma, Germany
  • Flecainid AAA
    AAA-Pharma, Germany
  • Flecainid Actavis
    Actavis, Denmark
  • Flecainid HEXAL
    Hexal, Germany
  • Flecainid Puren
    PUREN Pharma, Germany
  • Flecainid Sandoz
    Sandoz, Denmark; Sandoz, Norway
  • Flecainid Stada
    STADA, Iceland; STADA Nordic, Denmark
  • Flecainida Apotex
    Apotex, Spain
  • Flecainida Aurobindo
    Aurobindo, Spain
  • Flecainida Normon
    Normon, Spain
  • Flecainidacetat AL
    Aliud Pharma, Germany
  • Flecainidacetat Aurobindo
    Aurobindo, Germany
  • Flecainidacetat STADA
    Stada Arzneimittel, Germany
  • Flecainidacetat-Actavis
    PUREN Pharma, Germany
  • Flecainide
    Gerard, Ireland
  • Flecainide AA Pharma
    AA Pharma, Canada
  • Flecainide Acetate
    Actavis UK, United Kingdom; Amneal Pharmaceuticals, United States; ANI, United States; Apotex, United States; Aurobindo Pharma - Milpharm, United Kingdom; Brown & Burk, United Kingdom; Generics UK, United Kingdom; Sun Pharma, United States; Tillomed, United Kingdom; West-Ward, United States
  • Flecainide Acetate Actavis
    Actavis UK, Malta
  • Flecainide Acetate Aurobindo
    Aurobindo, Malta
  • Flecainide Acetate Central Procurement
    Central Procurement & Supplies Unit, Malta
  • Flécaïnide Arrow
    Arrow, France
  • Flécaïnide Biogaran
    Biogaran, France
  • Flécaïnide Biogaran LP
    Biogaran, France
  • Flecainide EG
    Eurogenerics, Belgium
  • Flécaïnide EG
    EG Labo, France
  • Flecainide EG 100mg
    Eurogenerics, Luxembourg
  • Flecainide EG Retard 100mg
    Eurogenerics, Luxembourg
  • Flecainide EG Retard 150mg
    Eurogenerics, Luxembourg
  • Flecainide EG Retard 200mg
    Eurogenerics, Luxembourg
  • Flecainide LEK
    Salutas Pharma, Macedonia
  • Flecainide Mylan
    Mylan, France
  • Flecainide Orion
    Orion Pharma, Finland
  • Flecainide Rafa 50mg
    Actavis, Israel
  • Flecainide Retard EG
    Eurogenerics, Belgium
  • Flécaïnide RPG
    Ranbaxy, France
  • Flecainide Sandoz
    Sandoz, Australia; Sandoz, Belgium; Sandoz, Italy
  • Flécaïnide Sandoz
    Sandoz, France
  • Flecainide Sandoz 100mg
    Sandoz, Luxembourg
  • Flecainide Teva
    Teva Italia, Italy
  • Flecaïnide Teva
    Teva Nederland, Netherlands
  • Flécaïnide Teva LP
    Teva Santé, France
  • Flécaïnide Zentiva LP
    Sanofi-Aventis, France
  • Flecainideacetaat
    Hexal, Netherlands; STADA, Netherlands
  • Flecainideacetaat Apotex
    Apotex Nederland, Netherlands
  • Flecaïnideacetaat Aurobindo
    Aurobindo, Netherlands
  • Flecaïnideacetaat CF
    Centrafarm, Netherlands
  • Flecaïnideacetaat Mylan
    Mylan, Netherlands
  • Flecaïnideacetaat ratiopharm
    ratiopharm, Netherlands
  • Flecaïnideacetaat retard CF
    Centrafarm, Netherlands
  • Flecaïnideacetaat retard Teva
    Teva Nederland, Netherlands
  • Flecaïnideacetaat Sandoz
    Sandoz, Netherlands
  • Flecaïnideacetaat Sandoz retard
    Sandoz, Netherlands
  • Flecainid-ratiopharm
    ratiopharm, Germany
  • Flecainid-Sandoz
    Hexal, Germany
  • Flecard
    Qualigen, Spain
  • Flecardia
    Win Medica, Greece
  • Flecarythm
    Ferrer-Galenica, Greece
  • Flecatab
    Alphapharm, Australia; Alphapharm, Taiwan
  • Flecateva
    Teva Pharma Belgium, Belgium
  • Flecateva Retard
    Teva Pharma Belgium, Belgium
  • Flecazela CR
    Disphar International, Netherlands
  • Flekainid Sandoz
    Sandoz, Slovakia
  • Flexavi CR
    Disphar International, Netherlands
  • Juneflecad
    Laboratorios Liconsa, Romania; Liconsa, Netherlands
  • Tambocor
    3M, Kuwait; Bausch & Lomb Pharma, Thailand; Cenexi, Israel; Eisai, Japan; IFET, Greece; iNova, Hong Kong; iNova, Malaysia; iNova, New Zealand; iNova, Philippines; iNova, Taiwan; iNova, South Africa; iNova Pharmaceuticals, Australia; Joongwae Shinyak, South Korea; Laboratorios Euromed Chile, Chile; Meda, Denmark; Meda, Estonia; Meda, Ireland; Meda, Malta; Meda, Norway; Meda, Romania; Meda, Sweden; Meda AB, Iceland; Meda Ph, Egypt; Meda Pharma, Belgium; Meda Pharma, Germany; Meda Pharma, Netherlands; Meda Pharmaceuticals, United Kingdom; Medicis Dermatologics, United States; More Pharma, Mexico; More Pharma Corporation, Costa Rica; More Pharma Corporation, Guatemala; More Pharma Corporation, Honduras; More Pharma Corporation, Panama; More Pharma Corporation, El Salvador
  • Tambocor 10%
    Eisai, Japan
  • Tambocor 100mg
    3 M Health Care, Oman; 3M Health Care, Israel; Meda, Luxembourg; MEDA Pharma, Switzerland
  • Tambocor 150mg/15ml
    Meda, Luxembourg; MEDA Pharma, Switzerland
  • Tambocor 50mg
    3M Health Care, Israel
  • Tambocor CR
    iNova, New Zealand; iNova, Philippines; Meda Pharma, Netherlands
  • Tambocor mite
    MEDA Pharma, Germany
  • Tambocor Retard
    Meda, Norway; Meda, Sweden
  • Tambocor XL
    Meda Pharmaceuticals, United Kingdom


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.